Term
|
Definition
CH 25 General Anesthetics
Intravenous Anesthetics
Barbiturates
Bind to GABAA receptor subunits facilitating Cl- channel opening; sedation and relief of anxiety
↓ BP, SV, CO
↓ CNS metabolism, O2 utilization,
cerebral blood flow
↓ Sensitivity of medullary respiratory center to CO2 (respiratory depressant)
|
Exacerbate porphyria
Respiratory depression,
Induces P450
|
Patients with cerebral swelling – head trauma, brain tumors (intracranial pressure not ↑)
|
|
|
|
Term
|
Definition
CH 25 General Anesthetics
Intravenous Anesthetics
Depression of central ventilator drive, transient apnea, ↓ BP, negative ionotropic effects
|
Prolonged administration can ↑ serum lipid levels; severe acidosis in presence of resp infections and possible neurologic sequelae upon withdrawal (in children);
pain at injection site, hypotonus, rarely tremors
|
Most popular IV anesthetic more rapid recovery, ↓ postop nausea and vomiting
Induction and maintenance of anesthesia, and prolonged sedation
|
|
|
|
Term
|
Definition
CH 25 General Anesthetics
Intravenous Anesthetics
Minimal cardiovascular and respiratory depression; rapid loss of consciousness with minimal hypotension, unchanged HR, low incidence of apnea
|
High incidence of pain on injection, myoclonic activity, postop nausea and vomiting, adrenocortical suppression
|
Induction of anesthesia in patients with limited cardiovascular reserve
No analgesic effects (administer with opioids)
|
|
|
|
Term
|
Definition
CH 25 General Anesthetics
Intravenous Anesthetics
Blocks glutamate’s effects at the
NMDA receptor
Stimulates the CNS
Inhibits norepi reuptake
Anesthetic & analgesic with cardiovascular stimulation;
↑ HR, BP, CO, cerebral blood flow, O2 consumption, intracranial pressure
|
High incidence of post-op psychic phenomena: disorientation,
sensory & perceptual illusions, vivid dreams
Psychosis
|
High-risk patients in
cardiogenic or septic shock
(due to cardio-stimulatory
properties)
Produces a dissociative
anesthetic state
|
|
|
|
Term
|
Definition
CH 25 General Anesthetics
Inhaled Anesthetics
Strong analgesia, cannot produce full anesthesia
|
Megaloblastic anemia
|
Inhaled anesthetics target the GABAA receptor Cl- channel, which is a major mediator of
inhibitory synaptic transmission. The anesthetics facilitate GABA-mediated inhibition, increasing the
sensitivity of the GABAA receptor for GABA.
Other sites of action include stimulation of inhibitory glycine receptors in the spinal cord and
inhibition of nicotinic receptors in the peripheral nervous system.
|
Acute Toxicity:
Malignant hyperthermia
Chronic Toxicity:
Prolonged exposure to most anesthetics can lead to renal insufficiency, mutagenicity,
carcinogenicity, hematotoxicity, and a higher incidence of miscarriages
|
|
|
|
Term
|
Definition
CH 25 General Anesthetics
Inhaled Anesthetics
Strong anesthetic; minor analgesia
|
Cardiac arrhythmias, severe Hepatic toxicity
|
|
|
Inhaled anesthetics target the GABAA receptor Cl- channel, which is a major mediator of
inhibitory synaptic transmission. The anesthetics facilitate GABA-mediated inhibition, increasing the
sensitivity of the GABAA receptor for GABA.
Other sites of action include stimulation of inhibitory glycine receptors in the spinal cord and
inhibition of nicotinic receptors in the peripheral nervous system.
|
Acute Toxicity:
Malignant hyperthermia
Chronic Toxicity:
Prolonged exposure to most anesthetics can lead to renal insufficiency, mutagenicity,
carcinogenicity, hematotoxicity, and a higher incidence of miscarriages
|
|
|
|
Term
|
Definition
CH 25 General Anesthetics
Inhaled Anesthetics
Inhaled anesthetics target the GABAA receptor Cl- channel, which is a major mediator of
inhibitory synaptic transmission. The anesthetics facilitate GABA-mediated inhibition, increasing the
sensitivity of the GABAA receptor for GABA.
Other sites of action include stimulation of inhibitory glycine receptors in the spinal cord and
inhibition of nicotinic receptors in the peripheral nervous system.
|
Acute Toxicity:
Malignant hyperthermia
Chronic Toxicity:
Prolonged exposure to most anesthetics can lead to renal insufficiency, mutagenicity,
carcinogenicity, hematotoxicity, and a higher incidence of miscarriages
|
|
|
|
Term
|
Definition
CH 25 General Anesthetics
Adjunct Drugs
Droperidol (a butyrophenone) and fentanyl administered together produce analgesia and amnesia and combinedwith nitrous oxide provide a state referred to as neuroleptanesthesia
|
|
Neuroleptanesthesia
|
|
|
|
Term
|
Definition
CH 25 General Anesthetics
Adjunct Drugs (Opioid Analgesic)
Opioid Side Effects: Histamine release, nausea
High doses used with benzodiazepines to achieve anesthetic state
|
Awareness during anesthesia and postop recall may occur; chest wall rigidity; ↑ postop opioid requirements due to tolerance
|
Cardiac or other major surgery when patient’s circulatory reserve is limited
|
|
|
|
Term
|
Definition
CH 25 General Anesthetics
Adjunct Drugs (Benzodiazepine)
Benzodiazepine Side Effects: Diplopia, nystagmus
Bind to GABAA receptor subunits facilitating Cl- channel opening; sedation and relief of anxiety
|
Large doses prolong recovery period and can produce anterograde amnesia
|
Premedication – sedative-anxiolytic with high incidence of amnesia
|
|
|
|